GLRX and chronic myelogenous leukemia, BCR-ABL1 positive: In another tumour model, STAT5 induced by Bcr-Abl in chronic myeloid leukemia (CML) cells inhibited the expression of Grx1, increasing ROS levels with consequently decrease of cell viability [191].